86 related articles for article (PubMed ID: 21890374)
1. Interferon regulatory factor-4 activates IL-2 and IL-4 promoters in cooperation with c-Rel.
Shindo H; Yasui K; Yamamoto K; Honma K; Yui K; Kohno T; Ma Y; Chua KJ; Kubo Y; Aihara H; Ito T; Nagayasu T; Matsuyama T; Hayashi H
Cytokine; 2011 Dec; 56(3):564-72. PubMed ID: 21890374
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the IL-21 gene by the NF-κB transcription factor c-Rel.
Chen G; Hardy K; Bunting K; Daley S; Ma L; Shannon MF
J Immunol; 2010 Aug; 185(4):2350-9. PubMed ID: 20639489
[TBL] [Abstract][Full Text] [Related]
3. JunB and c-Rel cooperatively enhance Foxp3 expression during induced regulatory T cell differentiation.
Son JS; Sahoo A; Chae CS; Hwang JS; Park ZY; Im SH
Biochem Biophys Res Commun; 2011 Apr; 407(1):141-7. PubMed ID: 21371435
[TBL] [Abstract][Full Text] [Related]
4. Deficient translocation of c-Rel is associated with impaired Th1 cytokine production in T cells from atopic dermatitis patients.
Dieckhoff K; Graf P; Beinhauer B; Schwaerzler C; Carballido JM; Neumann C; Zachmann K; Jung T
Exp Dermatol; 2005 Jan; 14(1):17-25. PubMed ID: 15660915
[TBL] [Abstract][Full Text] [Related]
5. Activation of IL-2 receptor alpha-chain gene by individual members of the rel oncogene family in association with serum response factor.
Pierce JW; Jamieson CA; Ross JL; Sen R
J Immunol; 1995 Aug; 155(4):1972-80. PubMed ID: 7636248
[TBL] [Abstract][Full Text] [Related]
6. Binding of c-Rel to STAT5 target sequences in HTLV-I-transformed T cells.
Sun SC; Maggirwar SB; Harhaj EW; Uhlik M
Oncogene; 1999 Feb; 18(7):1401-9. PubMed ID: 10050877
[TBL] [Abstract][Full Text] [Related]
7. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages.
Marecki S; Atchison ML; Fenton MJ
J Immunol; 1999 Sep; 163(5):2713-22. PubMed ID: 10453013
[TBL] [Abstract][Full Text] [Related]
8. Human T-cell leukemia virus type I tax activates transcription of the human monocyte chemoattractant protein-1 gene through two nuclear factor-kappaB sites.
Mori N; Ueda A; Ikeda S; Yamasaki Y; Yamada Y; Tomonaga M; Morikawa S; Geleziunas R; Yoshimura T; Yamamoto N
Cancer Res; 2000 Sep; 60(17):4939-45. PubMed ID: 10987310
[TBL] [Abstract][Full Text] [Related]
9. Regulation of IFN regulatory factor 4 expression in human T cell leukemia virus-I-transformed T cells.
Sharma S; Grandvaux N; Mamane Y; Genin P; Azimi N; Waldmann T; Hiscott J
J Immunol; 2002 Sep; 169(6):3120-30. PubMed ID: 12218129
[TBL] [Abstract][Full Text] [Related]
10. Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors.
Lee AH; Hong JH; Seo YS
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):131-8. PubMed ID: 10926836
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
McGuire KL; Iacobelli M
J Immunol; 1997 Aug; 159(3):1319-27. PubMed ID: 9233628
[TBL] [Abstract][Full Text] [Related]
12. The role of NF-Y and IRF-2 in the regulation of human IL-4 gene expression.
Li-Weber M; Davydov IV; Krafft H; Krammer PH
J Immunol; 1994 Nov; 153(9):4122-33. PubMed ID: 7930616
[TBL] [Abstract][Full Text] [Related]
13. Effects of vomitoxin (deoxynivalenol) on transcription factor NF-kappa B/Rel binding activity in murine EL-4 thymoma and primary CD4+ T cells.
Ouyang YL; Li S; Pestka JJ
Toxicol Appl Pharmacol; 1996 Oct; 140(2):328-36. PubMed ID: 8887449
[TBL] [Abstract][Full Text] [Related]
14. The transcriptionally active factors mediating the effect of the HTLV-I Tax transactivator on the IL-2R alpha kappa B enhancer include the product of the c-rel proto-oncogene.
Crenon I; Béraud C; Simard P; Montagne J; Veschambre P; Jalinot P
Oncogene; 1993 Apr; 8(4):867-75. PubMed ID: 8455941
[TBL] [Abstract][Full Text] [Related]
15. Repression of IRF-4 target genes in human T cell leukemia virus-1 infection.
Mamane Y; Grandvaux N; Hernandez E; Sharma S; Innocente SA; Lee JM; Azimi N; Lin R; Hiscott J
Oncogene; 2002 Oct; 21(44):6751-65. PubMed ID: 12360402
[TBL] [Abstract][Full Text] [Related]
16. Conserved high-affinity NF-kappa B binding site in the interferon regulatory factor-1 promoter is not occupied by NF-kappa B in vivo and is transcriptionally inactive.
Rein T; Schreck R; Willenbrink W; Neubert WJ; Zorbas H; Bäuerle PA
J Inflamm; 1995; 45(4):269-82. PubMed ID: 8867671
[TBL] [Abstract][Full Text] [Related]
17. Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells.
Hickey FB; Brereton CF; Mills KH
J Leukoc Biol; 2008 Jul; 84(1):234-43. PubMed ID: 18401006
[TBL] [Abstract][Full Text] [Related]
18. Enhanced interferon regulatory factor 3 binding to the interleukin-23p19 promoter correlates with enhanced interleukin-23 expression in systemic lupus erythematosus.
Smith S; Gabhann JN; Higgs R; Stacey K; Wahren-Herlenius M; Espinosa A; Totaro MG; Sica A; Ball E; Bell A; Johnston J; Browne P; O'Neill L; Kearns G; Jefferies CA
Arthritis Rheum; 2012 May; 64(5):1601-9. PubMed ID: 22127978
[TBL] [Abstract][Full Text] [Related]
19. Decreased c-rel activation contributes to aberrant interleukin-2 expression in CD4(+)T cells of aged rats.
Gong Z; Liu T; Wan Y; Hang Z; Tong X; Zhang B; Yang H; Zhang X; Zhang L; Jin G
Mol Immunol; 2014 Sep; 61(1):1-6. PubMed ID: 24853588
[TBL] [Abstract][Full Text] [Related]
20. Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene expression by rel/nuclear factor kappaB.
Grumont RJ; Gerondakis S
J Exp Med; 2000 Apr; 191(8):1281-92. PubMed ID: 10770796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
